Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.785 USD | +1.42% | +2.89% | -4.30% |
Apr. 22 | Adial Pharmaceuticals Granted US Patent for Genetic Diagnostic, AD04 Combination to Treat Alcohol Use Disorder | MT |
Apr. 12 | Top Premarket Decliners | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-4.30% | 7.14M | |
-1.67% | 104B | |
+6.79% | 97.47B | |
+5.71% | 22.25B | |
-12.58% | 21.68B | |
-9.70% | 18.2B | |
-39.98% | 17.02B | |
-10.14% | 16.36B | |
+6.99% | 14.39B | |
+36.79% | 12.37B |
- Stock Market
- Equities
- ADIL Stock
- News Adial Pharmaceuticals, Inc.
- Adial Pharmaceuticals Awarded Patent Combining Use of Genetic Diagnostic With AD04 to Treat Alcohol, Drug Dependence